- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Low T Cell Numbers
Total 1526 results
-
Hunan Cancer HospitalRecruitingChemotherapy Effect | NK/T-cell Lymphoma of Nasal Cavity | Immune Checkpoint Inhibitor | Epigenetic DisorderChina
-
The University of Hong KongUnknownNatural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin T-cell LymphomaHong Kong
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedHodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T-Cell LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Anhui Medical University; Henan Cancer Hospital and other collaboratorsRecruitingInduction Chemotherapy | Acute T-Lymphocytic Leukemia | T-cell Lymphoblastic Lymphoma Leukemia | T-cell/Myeloid Mixed Phenotype Acute LeukemiaChina
-
Zhejiang UniversityRecruitingT Lymphoblastic Leukemia/LymphomaChina
-
National Cancer Institute (NCI)TerminatedNeoplasms | Mycosis Fungoides | Cutaneous T-Cell LymphomaUnited States
-
Taiwan Mundipharma Pharmaceuticals Ltd.UnknownPeripheral T Cell Lymphoma | Progression, DiseaseTaiwan
-
University of MinnesotaTerminated
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin LymphomaChina
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
Sun Yat-sen UniversityCompletedRadiotherapy | Sintilimab | Anlotinib | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Early Stage | Peg-aspargase | Phase Two | OpenChina
-
The First Affiliated Hospital with Nanjing Medical...UnknownRelapse/Refratory Peripheral T Cell LymphomaChina
-
University of MiamiNational Cancer Institute (NCI)TerminatedLymphoma | Precancerous/Nonmalignant ConditionUnited States
-
Ruijin HospitalNot yet recruiting
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Institute of Hematology & Blood Diseases HospitalRecruitingPeripheral T Cell Lymphoma | Epigenetic RepressionChina
-
The First Affiliated Hospital of Soochow UniversityAffiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower... and other collaboratorsRecruiting
-
CStone PharmaceuticalsCompletedExtranodal Natural Killer/T-Cell LymphomaChina
-
CelgeneActive, not recruiting
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin Lymphoma | T-cell Acute Lymphoblastic LymphomaChina
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous... and other conditionsUnited States, Canada
-
Sorrento Therapeutics, Inc.RecruitingMycosis FungoidesUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Invivoscribe, Inc.; T-Cell Leukemia Lymphoma...Completed
-
Rochester General HospitalBausch Health Americas, Inc.; Rochester Skin Lymphoma Medical Group, PLLCWithdrawn
-
Jiangsu Simcere Biologics Co., LtdRecruitingAdvanced Solid Tumor | Cutaneous T Cell LymphomaChina
-
Rong TaoRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
National Cancer Institute (NCI)Completed
-
Acrotech Biopharma Inc.CompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, Italy
-
Fudan UniversityRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Fudan UniversityRecruitingPeripheral T-cell LymphomaChina
-
Rong TaoRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Kyowa Kirin, Inc.RecruitingCutaneous T Cell Lymphoma | ATLL | Leukemia/LymphomaUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
German CLL Study GroupGenzyme, a Sanofi Company; University of CologneCompletedT-cell-prolymphocytic LeukemiaGermany
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); NYU Langone Health and other collaboratorsCompleted
-
Mingzhi ZhangUnknownNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Sun Yat-sen UniversityFudan University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsUnknownHigh Risk | T-cell Lymphoma Adults | Previously UntreatedChina
-
BioCryst PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Ronald LevyAmerican Society of Clinical Oncology; Lymphoma Research FoundationCompletedMycosis Fungoides | Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterTakedaWithdrawnAnaplastic Large Cell Lymphoma | Classical Hodgkin Lymphoma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | CD30+ Peripheral T-cell Lymphoma
-
University College, LondonMerck Sharp & Dohme LLCActive, not recruitingCutaneous T Cell Lymphoma | Mycosis Fungoides/Sezary SyndromeUnited Kingdom
-
European Organisation for Research and Treatment...TerminatedEarly Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)France
-
Kura Oncology, Inc.AvailableHRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphomaUnited States
-
Peking UniversityPeking University International Hospital; Jiangxi Provincial Cancer Hospital; Shandong Tumor HospitalUnknownExperimental TumorChina
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
MillennixUnknownLymphomaUnited States